| Jonathan M Morgan, MD | |
|
1330 S. Ft. Harrison Ave, Clearwater, FL 33756 | |
| (727) 441-3588 | |
| (727) 461-1038 |
| Full Name | Jonathan M Morgan |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 24 Years |
| Location | 1330 S. Ft. Harrison Ave, Clearwater, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255350864 | NPI | - | NPPES |
| 272894000 | Medicaid | FL | |
| 16456 | Other | FL | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | ME88962 (Florida) | Primary |
| 207YS0123X | Otolaryngology - Facial Plastic Surgery | ME88962 (Florida) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Morton Plant Hospital | Clearwater, FL | Hospital |
| Mease Dunedin Hospital | Dunedin, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| West Coast Ear, Nose And Throat, Inc | 0941260103 | 19 |
News Archive
Researchers at Wayne State University have made a fundamental discovery and, in subsequent collaboration with scientists at La Jolla Institute for Allergy and Immunology (LIAI), are one step closer to the goal of developing the world's first T-cell peptide-based vaccine for heart disease - the number one killer in the nation.
Researchers from the Center for BrainHealth at The University of Texas at Dallas are investigating a potential new early indicator of the decline toward Alzheimer's disease: measuring the energy metabolism of the living human brain using cutting-edge imaging techniques.
The format of the original Hamilton Rating Scale for Depression (HAM-D) was unstructured: only general instructions were provided for rating individual items.
Inc. magazine ranked Signature Genomic Laboratories no. 1012 on its third annual Inc. 5000, an exclusive ranking of the nation's fastest-growing private companies. The company, which performs microarray-based diagnostic genetic testing of chromosome abnormalities in individuals with unexplained mental retardation and/or birth defects, experienced three-year sales growth of 302.9%, more than twice that of the Inc. 5000 industry median and over 12 times the industry benchmark. Signature was also ranked 70th of companies in the healthcare sector.
This study, published in the last 2010 issue of Psychotherapy and Psychosomatics, indicate that concomitant physical symptoms in patients with depression and anxiety are associated with a poorer prognosis of symptoms of depression and anxiety and that it might prove worthwhile to pay attention to the role of multiple physical symptoms in the process of tailoring interventions to meet the needs of depressed and anxious patients in primary care.
› Verified 9 days ago
| Entity Name | West Coast Ear, Nose & Throat, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346229440 PECOS PAC ID: 0941260103 Enrollment ID: O20041013000380 |
News Archive
Researchers at Wayne State University have made a fundamental discovery and, in subsequent collaboration with scientists at La Jolla Institute for Allergy and Immunology (LIAI), are one step closer to the goal of developing the world's first T-cell peptide-based vaccine for heart disease - the number one killer in the nation.
Researchers from the Center for BrainHealth at The University of Texas at Dallas are investigating a potential new early indicator of the decline toward Alzheimer's disease: measuring the energy metabolism of the living human brain using cutting-edge imaging techniques.
The format of the original Hamilton Rating Scale for Depression (HAM-D) was unstructured: only general instructions were provided for rating individual items.
Inc. magazine ranked Signature Genomic Laboratories no. 1012 on its third annual Inc. 5000, an exclusive ranking of the nation's fastest-growing private companies. The company, which performs microarray-based diagnostic genetic testing of chromosome abnormalities in individuals with unexplained mental retardation and/or birth defects, experienced three-year sales growth of 302.9%, more than twice that of the Inc. 5000 industry median and over 12 times the industry benchmark. Signature was also ranked 70th of companies in the healthcare sector.
This study, published in the last 2010 issue of Psychotherapy and Psychosomatics, indicate that concomitant physical symptoms in patients with depression and anxiety are associated with a poorer prognosis of symptoms of depression and anxiety and that it might prove worthwhile to pay attention to the role of multiple physical symptoms in the process of tailoring interventions to meet the needs of depressed and anxious patients in primary care.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan M Morgan, MD 1330 S. Ft. Harrison Ave, Clearwater, FL 33756 Ph: (727) 441-3588 | Jonathan M Morgan, MD 1330 S. Ft. Harrison Ave, Clearwater, FL 33756 Ph: (727) 441-3588 |
News Archive
Researchers at Wayne State University have made a fundamental discovery and, in subsequent collaboration with scientists at La Jolla Institute for Allergy and Immunology (LIAI), are one step closer to the goal of developing the world's first T-cell peptide-based vaccine for heart disease - the number one killer in the nation.
Researchers from the Center for BrainHealth at The University of Texas at Dallas are investigating a potential new early indicator of the decline toward Alzheimer's disease: measuring the energy metabolism of the living human brain using cutting-edge imaging techniques.
The format of the original Hamilton Rating Scale for Depression (HAM-D) was unstructured: only general instructions were provided for rating individual items.
Inc. magazine ranked Signature Genomic Laboratories no. 1012 on its third annual Inc. 5000, an exclusive ranking of the nation's fastest-growing private companies. The company, which performs microarray-based diagnostic genetic testing of chromosome abnormalities in individuals with unexplained mental retardation and/or birth defects, experienced three-year sales growth of 302.9%, more than twice that of the Inc. 5000 industry median and over 12 times the industry benchmark. Signature was also ranked 70th of companies in the healthcare sector.
This study, published in the last 2010 issue of Psychotherapy and Psychosomatics, indicate that concomitant physical symptoms in patients with depression and anxiety are associated with a poorer prognosis of symptoms of depression and anxiety and that it might prove worthwhile to pay attention to the role of multiple physical symptoms in the process of tailoring interventions to meet the needs of depressed and anxious patients in primary care.
› Verified 9 days ago
Matthew Clavenna, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1330 S Fort Harrison Ave, Clearwater, FL 33756 Phone: 727-216-0700 Fax: 727-216-0704 | |
Dr. Andrew Sean Mallon, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1330 S Fort Harrison Ave, Clearwater, FL 33756 Phone: 727-216-0700 Fax: 727-216-0704 | |
Dr. Scott Michael Greene, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1330 S Fort Harrison Ave, Clearwater, FL 33756 Phone: 727-441-3588 Fax: 727-461-1038 | |
Dr. Faisal Merchant, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1330 S Fort Harrison Ave, Clearwater, FL 33756 Phone: 727-216-0700 Fax: 727-216-0704 | |
Dr. Jerry Alan Margolin, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 501 S Lincoln Ave, Suite 26, Clearwater, FL 33756 Phone: 727-442-2193 Fax: 727-466-6483 | |
Dr. Alexander K Malone, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3131 N Mcmullen Booth Rd, Clearwater, FL 33761 Phone: 727-341-0551 Fax: 727-341-0332 |